VentriGel The results of a FDA-approved Phase 1 clinical trial indicate that a hydrogel (VentriGel, Ventrix) can be safely injected via catheter into patients who had a myocardial infarction in the past two to 36 months. The trial is the first to test a hydrogel designed to repair cardiac tissue, and it [...]